EXL lifts 2026 outlook on 16% revenue surge as iMerit deal nears completion
EXLS sits 26% above its 52-week low of $24.85.
Summary
ExlService Holdings posted Q2 2026 revenue of $594.8 million, a 15.6% increase, and raised its full-year guidance to $2.39–$2.42 billion, incorporating contributions from the pending iMerit acquisition.
Key Events · Earnings and Guidance · EXLS
-
Q2 Revenue Jumps 15.6%
Revenue reached $594.8 million, driven by broad-based growth across all segments, with Healthcare and Life Sciences up 22% year-over-year.
-
Adjusted EPS Surges 22.3%
Adjusted diluted EPS hit $0.59, up from $0.49 a year ago, while GAAP EPS rose 4.9% to $0.42, reflecting higher stock-based compensation and acquisition costs.
-
Full-Year Guidance Raised
Management now expects 2026 revenue of $2.39–$2.42 billion (14–16% growth) and adjusted diluted EPS of $2.25–$2.29 (16–18% growth), up from prior guidance of $2.30–$2.33 billion and $2.18–$2.23, respectively.
-
iMerit Acquisition to Close July 31
The $310 million acquisition of iMerit is expected to close on July 31, 2026, adding $28–$32 million in revenue for the remainder of the year and strengthening EXL's enterprise AI capabilities.
Analysis · EXLS · Trade & Services
A strong second quarter saw revenue climb 15.6% to $594.8 million and adjusted EPS jump 22.3% to $0.59. Bolstered by this momentum, management raised full-year organic revenue growth guidance to 13–14% and now projects total revenue of $2.39–$2.42 billion, which includes $28–$32 million from the iMerit acquisition expected to close July 31. The upgraded outlook underscores confidence in the data and AI strategy, though GAAP EPS growth was a more modest 4.9%, weighed down by higher stock-based compensation and acquisition-related costs.
At the time of this filing, EXLS was trading at $31.20 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $4.7B. The 52-week trading range was $24.85 to $47.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.